Placebo for PF-06651600-15, 50 mg, DEXAMETHASONE, Ritlecitinib tosilate, Placebo for PF-06651600-15, 100 mg, Ritlecitinib Tosilate
B7981080
Phase 3 small_molecule active
Quick answer
Placebo for PF-06651600-15, 50 mg, DEXAMETHASONE, Ritlecitinib tosilate, Placebo for PF-06651600-15, 100 mg, Ritlecitinib Tosilate for nonsegmental vitiligo is a Phase 3 program (small_molecule) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer Ireland Pharmaceuticals Unlimited Company
- Indication
- nonsegmental vitiligo
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active